<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0003074'>Hyperglycemia</z:hpo> causes many of the pathological consequences of both type 1 and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Much of this damage is suggested to be a consequence of elevated production of reactive oxygen species by the <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> respiratory chain during <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0001427'>Mitochondrial</z:hpo> radical production associated with <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> will also disrupt <z:chebi fb="105" ids="17234">glucose</z:chebi>-stimulated insulin secretion by pancreatic beta-cells, because pancreatic beta-cells are particularly susceptible to oxidative damage </plain></SENT>
<SENT sid="3" pm="."><plain>Therefore, <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> radical production in response to <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> contributes to both the progression and pathological complications of <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>Consequently, strategies to decrease <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> radical production and oxidative damage may have therapeutic potential </plain></SENT>
<SENT sid="5" pm="."><plain>This could be achieved by the use of <z:chebi fb="11" ids="22586">antioxidants</z:chebi> or by decreasing the <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> membrane potential </plain></SENT>
<SENT sid="6" pm="."><plain>Here, we outline the background to these strategies and discuss how <z:chebi fb="11" ids="22586">antioxidants</z:chebi> targeted to mitochondria, or selective <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> uncoupling, may be potential therapies for <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>